Gabriele Pollara

@gpollara.bsky.social

Infectious Diseases doctor (at UCLH) and academic (at UCL). Research focuses on host-pathogen interactions in TB, leprosy and UTIs. What are the immune, epithelial and stromal cell responses involved, and could they be targets for host-directed therapies?

Closes tonight at 23:59! Last chance to apply for this #job with @gpollara.bsky.social and me! 👇 #UTISky #MicroSky

Prof Jenny Rohn@jennyrohn.bsky.social · 2d ago

Closing soon! Great research role joint with @gpollara.bsky.social and me at @uclmedsci.bsky.social Come for the mystery of how bacteria affect the human bladder during recurrent #UTI - stay for the immunology, 'omics, innovative 3D urothelial modelling & friendly atmosphere! rb.gy/xmw5b5 #UTISky

Please do consider applying for this exciting lab role with @gpollara.bsky.social and me - nice blend of advanced culture models, immunology, microbiology and ‘omics, in our friendly Central London labs. Closes 2 Oct, please amplify! Happy to chat informally #UTI #UTISky

Gabriele Pollara@gpollara.bsky.social · 2w ago

🚨 NEW RESEARCH TECHNICIAN POST 🚨 👉 Interested in understanding the biology of recurrent UTI? 👉 Keen to work in my own and @jennyrohn.bsky.social research groups at UCL? Then please do take a look at new position available 👇. Informal enquiries encouraged. #UTISky www.ucl.ac.uk/work-at-ucl/...

🚨 NEW RESEARCH TECHNICIAN POST 🚨 👉 Interested in understanding the biology of recurrent UTI? 👉 Keen to work in my own and @jennyrohn.bsky.social research groups at UCL? Then please do take a look at new position available 👇. Informal enquiries encouraged. #UTISky www.ucl.ac.uk/work-at-ucl/...

UCL – University College London

UCL is consistently ranked as one of the top ten universities in the world (QS World University Rankings 2010-2022) and is No.2 in the UK for research power (Research Excellence Framework 2021).

ucl.ac.uk

When I have a spare moment (badaboom! 😅) going to need to read this carefully. On face of it illustrates trade offs at the edge of minimal Abx treatment durations. What worse outcomes is one willing to accept in return for shorter treatment duration? #IDSky #MedSky www.nejm.org/doi/full/10....

Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis | NEJM

In patients with infective endocarditis on the left side of the heart, the current recommendation of up to 6 weeks of antibiotic therapy is based largely on expert consensus opinion. Whether a clin...

nejm.org

Delighted to have contributed (a little) to this - dissecting role of urine, flow and phages on E. coli-urothelial interaction. Most remarkable to me was ability of phages to kill intracellular bacteria AND alter the host inflammatory response. "How" is the next interesting question... 🤔 #UTISky

Prof Jenny Rohn@jennyrohn.bsky.social · 4w ago

Thrilled our latest paper out @natureportfolio.nature.com Nature Comms, lead author @microberamon.bsky.social, who developed P-FLO, a urine-flowing human micro-bladder model in collab with Oxford & Leicester to understand #UTI biology & treatment failure 1/4 #UTISky www.nature.com/articles/s41...

Excited to share this “Insight” @jem.org about an amazing new finding by Zhou, Zhang, Ye, Staeheli &co showing that type III interferons #IFNL also signal in #fibroblasts driving renal #fibrosis! #InterferonPower! #EveryCellIsAnImmuneCell! #FriendsOrFoes!

Journal of Experimental Medicine@jem.org · 3mo ago

IFNλ works at mucosal surfaces by signaling in epithelial cells and selected immune cells. Zhou, Zhang et al. (rupress.org/jem/article/...) demonstrate that IFNλ also signals in kidney fibroblasts sustaining renal #fibrosis. @lozanzi.bsky.social highlights the findings: rupress.org/jem/article/...

Great post @apsmunro.bsky.social! Doing more is such a natural reaction. But even 'benign' interventions may likely be harmful when tested properly. I'm yet to know of a trial for sepsis where adding antibiotics has been beneficial (outside of TB where we do it to prevent emergence of resistance).

Alasdair Munro@apsmunro.bsky.social · 4mo ago

My new post looks at two antimicrobials which have been routinely used and even recommended in guidelines despite a lack of RCT evidence In the last few weeks they’ve both been shown to have no benefit, and worse, high probability of harm - killing patients A lesson we keep failing to learn